sandostatin lar powder for suspension, sustained-release
novartis pharmaceuticals canada inc - octreotide (octreotide acetate) - powder for suspension, sustained-release - 20mg - octreotide (octreotide acetate) 20mg - miscellaneous therapeutic agents
sandostatin lar powder for suspension, sustained-release
novartis pharmaceuticals canada inc - octreotide (octreotide acetate) - powder for suspension, sustained-release - 30mg - octreotide (octreotide acetate) 30mg - miscellaneous therapeutic agents
sandostatin lar 10mg
novartis corporation (malaysia) sdn. bhd. - octreotide -
sandostatin lar 20mg
novartis corporation (malaysia) sdn. bhd. - octreotide -
sandostatin lar 30mg
novartis corporation (malaysia) sdn. bhd. - octreotide -
sandostatin®lar® 20mg
1 vial of drug product + 1 prefilled syringe of vehicle + 1 safety injection needle + 1 vial adapter -
sandostatin 100 mcg/ml solution for injection
شركة مستودع الأدوية الأردني - the jordan drugstore co - octreotide 100 mcg/ml - 100 mcg/ml
sandostatine 100 µg/1 ml inj. sol. s.c./i.v. amp.
novartis pharma sa-nv - octreotide 0,1 mg - solution for injection - 100 microgram/1 ml - octreotide 0.1 mg - octreotide
sandostatine 500 µg/1 ml inj. sol. s.c./i.v. amp.
novartis pharma sa-nv - octreotide 0,5 mg - solution for injection - 500 microgram/1 ml - octreotide 0.5 mg - octreotide
sandostatine long acting repeatable 30 mg inj. susp. (pwdr. + solv.) i.m. pre-filled syr. vial
novartis pharma sa-nv - octreotide acetate 33,6 mg - eq. octreotide 30 mg - powder and solvent for suspension for injection - 30 mg - octreotide acetate 33.6 mg - octreotide